Cargando…
In Vivo Organic Bioelectronics for Neuromodulation
[Image: see text] The nervous system poses a grand challenge for integration with modern electronics and the subsequent advances in neurobiology, neuroprosthetics, and therapy which would become possible upon such integration. Due to its extreme complexity, multifaceted signaling pathways, and ∼1 kH...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874920/ https://www.ncbi.nlm.nih.gov/pubmed/35050623 http://dx.doi.org/10.1021/acs.chemrev.1c00390 |
_version_ | 1784657801755230208 |
---|---|
author | Berggren, Magnus Głowacki, Eric D. Simon, Daniel T. Stavrinidou, Eleni Tybrandt, Klas |
author_facet | Berggren, Magnus Głowacki, Eric D. Simon, Daniel T. Stavrinidou, Eleni Tybrandt, Klas |
author_sort | Berggren, Magnus |
collection | PubMed |
description | [Image: see text] The nervous system poses a grand challenge for integration with modern electronics and the subsequent advances in neurobiology, neuroprosthetics, and therapy which would become possible upon such integration. Due to its extreme complexity, multifaceted signaling pathways, and ∼1 kHz operating frequency, modern complementary metal oxide semiconductor (CMOS) based electronics appear to be the only technology platform at hand for such integration. However, conventional CMOS-based electronics rely exclusively on electronic signaling and therefore require an additional technology platform to translate electronic signals into the language of neurobiology. Organic electronics are just such a technology platform, capable of converting electronic addressing into a variety of signals matching the endogenous signaling of the nervous system while simultaneously possessing favorable material similarities with nervous tissue. In this review, we introduce a variety of organic material platforms and signaling modalities specifically designed for this role as “translator”, focusing especially on recent implementation in in vivo neuromodulation. We hope that this review serves both as an informational resource and as an encouragement and challenge to the field. |
format | Online Article Text |
id | pubmed-8874920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-88749202022-02-28 In Vivo Organic Bioelectronics for Neuromodulation Berggren, Magnus Głowacki, Eric D. Simon, Daniel T. Stavrinidou, Eleni Tybrandt, Klas Chem Rev [Image: see text] The nervous system poses a grand challenge for integration with modern electronics and the subsequent advances in neurobiology, neuroprosthetics, and therapy which would become possible upon such integration. Due to its extreme complexity, multifaceted signaling pathways, and ∼1 kHz operating frequency, modern complementary metal oxide semiconductor (CMOS) based electronics appear to be the only technology platform at hand for such integration. However, conventional CMOS-based electronics rely exclusively on electronic signaling and therefore require an additional technology platform to translate electronic signals into the language of neurobiology. Organic electronics are just such a technology platform, capable of converting electronic addressing into a variety of signals matching the endogenous signaling of the nervous system while simultaneously possessing favorable material similarities with nervous tissue. In this review, we introduce a variety of organic material platforms and signaling modalities specifically designed for this role as “translator”, focusing especially on recent implementation in in vivo neuromodulation. We hope that this review serves both as an informational resource and as an encouragement and challenge to the field. American Chemical Society 2022-01-20 2022-02-23 /pmc/articles/PMC8874920/ /pubmed/35050623 http://dx.doi.org/10.1021/acs.chemrev.1c00390 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Berggren, Magnus Głowacki, Eric D. Simon, Daniel T. Stavrinidou, Eleni Tybrandt, Klas In Vivo Organic Bioelectronics for Neuromodulation |
title | In Vivo Organic Bioelectronics for
Neuromodulation |
title_full | In Vivo Organic Bioelectronics for
Neuromodulation |
title_fullStr | In Vivo Organic Bioelectronics for
Neuromodulation |
title_full_unstemmed | In Vivo Organic Bioelectronics for
Neuromodulation |
title_short | In Vivo Organic Bioelectronics for
Neuromodulation |
title_sort | in vivo organic bioelectronics for
neuromodulation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874920/ https://www.ncbi.nlm.nih.gov/pubmed/35050623 http://dx.doi.org/10.1021/acs.chemrev.1c00390 |
work_keys_str_mv | AT berggrenmagnus invivoorganicbioelectronicsforneuromodulation AT głowackiericd invivoorganicbioelectronicsforneuromodulation AT simondanielt invivoorganicbioelectronicsforneuromodulation AT stavrinidoueleni invivoorganicbioelectronicsforneuromodulation AT tybrandtklas invivoorganicbioelectronicsforneuromodulation |